HIGHLIGHTS
- who: Markus Stana and colleagues from the Department of Radiation Oncology, Paracelsus Medical University, Salzburg, Austria have published the Article: Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate, in the Journal: Cancers 2023, 15, x FOR PEER REVIEW of 21/03/2023
- what: The aim of the current analysis was to correlate DLCO with pneumonitis and radiation dose. This study has two endpoints: clinically relevant pneumonitis, i.e., grade 2 or higher, and DLCO decline of 10% or more. The authors intended to model the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.